Form 4 for CVS CVS Health
Accepted 2024-04-03 00:00:00 ET · period of report 2024-04-01 · accession 0001127602-24-012274 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-04-03 | 2024-04-01 | CVS | Chaguturu Sreekanth K | EVP, Chief Medical Off | A - Grant | $79.56 | +6,913 | 23.7K | +41% | +$550.0K |
| DM | 2024-04-03 | 2024-04-01 | CVS | Chaguturu Sreekanth K | EVP, Chief Medical Off | F - Tax | $79.56 | -2,298 | 12.0K | -16% | -$182.8K |
| D | 2024-04-03 | 2024-04-01 | CVS | Chaguturu Sreekanth K | EVP, Chief Medical Off | A - Grant | $79.56 | +28.7K | 28.7K | New | +$2.29M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock (Restricted) | 2024-04-01 | A | A | 6,913 | $79.56 | 23,666 | D | — | — | |
| 2 | Common | Common Stock | 2024-04-01 | F | D | 825 | $79.56 | 11,211.98 | D | — | — | |
| 3 | Common | Common Stock | 2024-04-01 | F | D | 1,473 | $79.56 | 12,036.98 | D | — | — | |
| 4 | Derivative | Stock Option | 2024-04-01 | A | A | 28,735 | $79.56 | 28,735 | D | $79.56 · 2025-04-01 to 2034-04-01 | 28,735 Common Stock |